SP-MHCI-0706-2

Human Abl interactor 2 145-153, ILDDIGHGV

US$169.00

In stock

Description

About Human Abl interactor 2 145-153, ILDDIGHGV

The Human Abl interactor 2 Peptide (IEDB: 156689) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Abl interactor 2 Peptide, H-ILDDIGHGV-OH (Uniprot: Q9NYB9 aa: 145-153) from JPT is produced under strict quality control and quality management.

Human Abl interactor 2 145-153, ILDDIGHGV - Specifications

  • Peptide sequence: H-ILDDIGHGV-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Breast cancer, Ovarian cancer, Prostate cancer
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human Abl interactor 2 145-153, ILDDIGHGV

References:
Read References with JPT’s Antigen Peptides
Human Abl interactor 2 145-153, ILDDIGHGV has been described in:
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients., J Transl Med, 2012 (PMID: 22862954)
Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires., J Immunol, 2011 (PMID: 21209280)
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity., Nature, 2022 (PMID: 34814158)

Documentation

Documentation for Human Abl interactor 2 145-153, ILDDIGHGV

Properties

Properties of Human Abl interactor 2 145-153, ILDDIGHGV

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Breast cancer, Ovarian cancer, Prostate cancer
Layout: Freeze-dried in glass vial
Organism: Human
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human Abl interactor 2 145-153, ILDDIGHGV

Information Values
Sequence: H-ILDDIGHGV-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote